Biotechnocolgy - Oncology
Where Cancer Treatment Gets Personal
Within every cell of every person is a genetic blueprint. Known as the genome, this blueprint instructs the cell how to respond to its environment, when to reproduce, and when to die.

These genetic blueprints help to explain why each one of us is unique. They also explain why different cells and different patients respond to cancer treatment in different ways—and why one person may respond favorably to a drug, while another may experience debilitating side effects with little or no therapeutic benefit.

At Cell Therapeutics, Inc. (CTI), we use genomic information to develop a personalized approach to cancer therapy with the goal of making standard-of-care treatment less toxic and more effective for individual patients. Our approach is based on matching a drug candidate to a person's genetic profile along with other clinical and diagnostic information to achieve the highest anti-tumor activity, at the lowest dose, and with the fewest side effects. This personalized information can also be used to identify patients for clinical trials who are most likely to respond to the drug candidate.

Significant progress has already been made. Using a personalized approach to guide our drug development and commercialization programs may potentially lower our drug development costs, shorten approval time, and help improve the lives of patients by treating cancer according to each individual's genetic blueprint